Page last updated: 2024-09-03
1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and dinoprostone
1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene has been researched along with dinoprostone in 1 studies
Compound Research Comparison
| Studies (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Trials (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Recent Studies (post-2010) (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 30 | 0 | 23 | 29,105 | 1,346 | 6,357 |
Protein Interaction Comparison
| Protein | Taxonomy | 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gescher, AJ; Potter, GA; Ruparelia, KC; Sale, S; Steward, WP; Tunstall, RG | 1 |
Other Studies
1 other study(ies) available for 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and dinoprostone
| Article | Year |
|---|---|
Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
Topics: Adenoma; Animals; Antineoplastic Agents, Phytogenic; Chemoprevention; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Female; Genes, APC; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Resveratrol; Ribonucleotide Reductases; Stilbenes; Tissue Distribution | 2005 |